Researchers at the University of California, Davis, led by Sara K. Pintwala and Patrick M. Fuller, used single-nucleus RNA sequencing to profile individual neurons from the lateral hypothalamus of adult female and male mice. The technique captures the complete transcriptome — the full inventory of genes being actively read — from thousands of individual cell nuclei at once. Tissue was collected precisely at the onset of the dark phase, zeitgeber time 12, a biologically charged moment when nocturnal animals transition from rest to activity and when competing drives like feeding, exploration, and wakefulness surge together.

The team sequenced more than 85,000 nuclei in total, ultimately isolating 33,235 high-quality neuronal nuclei — 16,432 from females and 16,803 from males. After correcting for ambient RNA contamination, removing doublets, and integrating the datasets to control for batch effects, the researchers asked a deceptively simple question: do male and female lateral hypothalamic neurons differ in the genes that build and receive circadian signals?

The first surprise was what they did not find. When the researchers clustered all the nuclei together using unsupervised computational methods, the analysis revealed 24 distinct neuronal clusters — and every single one contained cells from both sexes. There was no evidence of sex-specific neuron classes, and the relative proportions of major cell types were nearly identical between males and females. Glutamatergic, GABAergic, orexin-producing, and melanin-concentrating hormone-associated populations were all represented at matching ratios, with odds ratios hovering close to 1.0. Structurally, the male and female lateral hypothalamus looked like the same brain region.

But beneath that conserved architecture, the molecular machinery told a different story. The researchers focused on a curated panel of clock and circadian signaling genes: the core activators Clock, Arntl (which encodes BMAL1), and Npas2; the repressors Per1, Per2, Per3, Cry1, and Cry2; auxiliary regulators such as Nr1d1, Nr1d2, and the ROR family; and receptors for the suprachiasmatic nucleus’s signature neuropeptides, including vasoactive intestinal peptide (VIP), arginine vasopressin (AVP), gastrin-releasing peptide, neuromedin S, cholecystokinin, and melatonin. Differential expression testing, corrected for false discovery, uncovered 15 genes whose expression differed significantly between the sexes.

The pattern of those differences was strikingly coherent. Female-derived neurons were enriched for the vasopressin receptor Avpr1a, the melatonin receptor Mtnr1b, the clock repressors Per2 and Per3, and the auxiliary regulators Nr1d1, Nr1d2, and Rora. Male-derived neurons, by contrast, showed enrichment for the VIP receptor Vipr2, along with Nmur2 and Cckar — receptors for neuromedin and cholecystokinin signaling — and, notably, for the core positive-limb oscillator genes Clock, Npas2, and Arntl, plus Per1, Cry1, and Rorb. In other words, the two sexes appeared to weight different limbs of the same circadian feedback loop, and different neuromodulatory input channels, across shared neuronal populations.

These motifs repeated across cell types. In glutamatergic neurons, females preferentially expressed AVP and melatonin-related transcripts while males emphasized VIP and CCK receptors alongside Npas2 and Clock. In GABAergic neurons, female enrichment again centered on Nr1d2, Per2, Per3, Rora, and the melatonin receptor Mtnr1a, while males showed elevated Nmur2, Rorb, Vipr2, Per1, Cry1, Arntl, and Clock. Among the peptidergic populations, differences were subtler but still present: Npas2 was enriched in female orexin neurons, while male melanin-concentrating hormone neurons showed enrichment for Rora, Cry1, Arntl, Npas2, and Mtnr1a. The consistency across excitatory, inhibitory, and neuropeptide-specific populations suggests a coordinated, system-level shift in how temporal information is processed, rather than random noise.

The functional implications are considerable. AVP signaling from the suprachiasmatic nucleus is a principal conduit of circadian output, critical for synchrony and phase regulation, while VIP is essential for keeping pacemaker neurons firing in unison. Neuromedin S-producing neurons act as pacemakers that couple clock cells across the circadian network, and cholecystokinin pathways have been implicated in circadian adaptation under changing photoperiods. If female lateral hypothalamic neurons are transcriptionally primed to receive vasopressin-dominant signals while male neurons favor VIP, neuromedin, and CCK inputs, then the same upstream timing information from the master clock could be translated into different downstream behavioral and physiological outputs in each sex — different thresholds for arousal, feeding, stress responsiveness, and sleep-wake transitions at the same time of day.

The study also mapped sex hormone receptor expression across all lateral hypothalamic neuron types, finding that androgen receptor transcripts were most abundant, estrogen receptor 1 moderate, and estrogen receptor 2 lowest, in both sexes. Because estrogen receptor 1 functions as a ligand-activated transcription factor known to drive expression of Per2 and Clock in hypothalamic neurons, its widespread presence identifies a concrete molecular route through which circulating steroids could reshape circadian transcription in a sex-dependent manner. This aligns with earlier work showing that androgens alter the magnitude of light-induced phase shifts and that estrogen signaling stabilizes firing synchrony in the suprachiasmatic nucleus.

The authors are careful about what their data can and cannot show. Because tissue was sampled at a single circadian timepoint in gonad-intact animals without estrous-cycle staging, the findings cannot establish whether the observed differences reflect stable sex dimorphism, fluctuating endocrine state, circadian phase, or interactions among all three. Nor can a snapshot at dark-phase onset reveal oscillatory amplitude or phase relationships across the full 24-hour cycle. What the study does establish is a framework: sexual dimorphism in the lateral hypothalamus emerges not through fundamentally distinct neuronal populations but through subtle, reproducible, and coordinated shifts in molecular signaling architecture — a differential tuning of shared circuits. As circadian and sleep medicine increasingly confront sex differences in rhythm period, amplitude, and disease vulnerability, the message is clear: the same clock may tick in everyone, but males and females may hear it through different molecular ears.

Subject of Research: Sex differences in circadian clock gene and neuropeptide receptor expression in the lateral hypothalamus

Article Title: Sex-associated circadian signaling signatures in the lateral hypothalamus

Article References: Pintwala, S. K., & Fuller, P. M. (2026). Sex-associated circadian signaling signatures in the lateral hypothalamus. Frontiers in Sleep, 5, 1895831. https://doi.org/10.3389/frsle.2026.1895831

Image Credits: AI Generated

DOI: 10.3389/frsle.2026.1895831

Keywords: lateral hypothalamus, circadian rhythms, single-nucleus RNA sequencing, sex differences, suprachiasmatic nucleus, orexin neurons, melanin-concentrating hormone, vasoactive intestinal peptide, arginine vasopressin, clock genes, hypothalamus, sleep-wake regulation

The core of the review is a synthesis of how volatile and intravenous anesthetics alter clock function in rodent and cellular systems. These effects are not uniform; they depend on which agent is used and on the circadian phase at which the drug is delivered. Propofol, sevoflurane, and other anesthetics appear to interfere with the molecular oscillator at several levels. One proposed route involves GABAergic and glutamatergic modulation of the neural signals that normally entrain the master clock in the suprachiasmatic nucleus to the light-dark cycle. Another involves transcriptional and chromatin-level repression of the CLOCK-BMAL1 complex and its PER and CRY feedback partners, the core loop that generates roughly 24-hour rhythms in gene expression throughout the body. A third route is metabolic: anesthetics may couple to the clock through signaling hubs such as CaMK-CREB, AMPK, SIRT1, and GSK-3β, enzymes that link cellular energy state and post-translational modification to the timing machinery.

What makes this mechanistic picture compelling in rodents and cell culture is also what limits it. The review is explicit that none of these specific mechanisms has been confirmed in humans. Human perioperative physiology is confounded by factors that animal models cannot fully reproduce: the tissue injury of surgery itself, opioid analgesia, preoperative fasting, the inflammatory response to trauma, and the radically disrupted light-dark exposure of intensive care units and hospital wards. In patients, the effects of anesthetics on circadian biology are inseparable from these overlapping stressors, all of which independently suppress the amplitude of the melatonin rhythm, delay its nighttime onset, and promote internal desynchrony, the state in which centrally and peripherally governed rhythms drift out of alignment with one another.

Melatonin itself is the other half of the axis, and the review draws a pharmacologically important distinction that is often blurred in the clinical literature. Melatonin signals through two G-protein-coupled receptors, MT1 and MT2, and activation of these receptors produces chronobiotic effects, shifting the timing of circadian phase, as well as anxiolytic and antinociceptive effects. These receptor-mediated actions operate at the doses achievable with standard oral supplementation. By contrast, a separate body of literature attributes to melatonin mitochondrial protection, antioxidant and redox modulation, and anti-inflammatory actions. The review emphasizes that these cytoprotective effects have been described almost exclusively in animal and cellular models, and that they require substantially higher exposures than receptor-level signaling. The two arms of melatonin pharmacology are therefore distinct, and the authors argue they should not be pooled when interpreting trial results or designing new studies, because a dose that engages MT1 and MT2 signaling will not necessarily achieve the concentrations at which mitochondrial and anti-inflammatory effects have been observed in preclinical systems.

On the clinical side, the most consistently supported indication is preoperative anxiolysis in adults. Across trials, melatonin given before surgery reduces anxiety with an effect comparable to standard benzodiazepine premedication in many studies, and with a favorable side-effect profile. This is the one application where the evidence base is coherent enough to support routine consideration. Beyond the preoperative period, the picture becomes markedly less certain. Evidence for melatonin’s benefit on postoperative sleep quality, on analgesia and opioid sparing, on the prevention of postoperative delirium, and on organ protection such as myocardial or renal preservation is heterogeneous, with trials of varying quality, dosing schemes, and patient populations producing conflicting results. The overall certainty of that evidence is low, and the review does not attempt to paper over the contradictions.

One of the most consequential points in the review concerns how clinical trials have been designed. Most studies to date have used fixed clock-time dosing, giving melatonin at, say, 22:00 or 60 minutes before surgery, without measuring the patient’s internal circadian phase or the achieved plasma concentration of the drug. This matters because melatonin’s chronobiotic effect is phase-dependent: the same dose can advance, delay, or leave unaffected the circadian clock depending on when it is given relative to the individual’s internal night. A trial that ignores circadian phase and never verifies drug exposure cannot distinguish between two very different explanations for a null result: that the mechanism itself is ineffective in surgical patients, or that the intervention was inadequate, delivered at the wrong biological time or at a dose that failed to reach the relevant compartment. The review argues that this design flaw has likely obscured real effects in the existing literature and that future trials must be phase-aware and exposure-informed.

The perioperative environment itself is a circadian disruptor of considerable magnitude. Patients scheduled for surgery are typically fasted, often receive their anesthetic at times that bear no relation to their habitual sleep-wake cycle, and are then nursed under continuous artificial light, frequently in intensive care settings where nocturnal light exposure and noise fragment sleep. Opioids suppress rapid eye movement sleep and alter the timing of nocturnal hormone release. Surgical inflammation feeds back on the hypothalamic-pituitary-adrenal axis, which in turn modulates the pineal gland. The result is a constellation of internal desynchrony that is already established before any specific pharmacological effect of the anesthetic on the molecular clock is considered. Any therapeutic strategy that targets the circadian system in surgical patients must therefore contend with this broader environmental and inflammatory context, not just with the direct actions of propofol or sevoflurane on CLOCK-BMAL1 signaling.

For clinicians, the practical takeaways are relatively modest but concrete. Preoperative oral melatonin for anxiolysis in adult patients is supported by the most consistent evidence and can be considered as an alternative or adjunct to benzodiazepine premedication, particularly in settings where respiratory depression is a concern. Beyond that, the review refrains from endorsing melatonin for postoperative delirium prevention, sleep promotion, or organ protection as standard practice, because the trials are too inconsistent and too small to support firm recommendations. What the review does offer is a framework for the next generation of studies: trials that stratify or randomize by circadian phase, that measure plasma melatonin concentrations to confirm exposure, that separate receptor-mediated from high-dose cytoprotective hypotheses, and that are adequately powered to detect the effect sizes that the preclinical literature would predict.

The broader significance of the work lies in its reframing of anesthesia as an interaction with a temporally organized biological system rather than a reversible switch applied to a physiologically neutral one. The molecular clock influences drug metabolism, immune responses, inflammatory resolution, and sleep architecture, all of which are central to perioperative outcomes. If anesthetic agents genuinely repress CLOCK-BMAL1/PER-CRY signaling and desynchronize peripheral clocks, then the timing of surgery and the design of anesthetic regimens could, in principle, be optimized to minimize circadian disruption, with downstream benefits for recovery, delirium risk, and long-term cognitive outcomes. That possibility remains speculative until the human mechanisms are confirmed, but the review makes a strong case that the question is now answerable with the right experimental design.

The circadian-melatonin axis, the authors conclude, remains a plausible perioperative target, but one whose clinical translation has been hampered more by trial methodology than by the absence of underlying biology. The mechanistic work in rodents and cells has generated specific, testable hypotheses about GABAergic entrainment, chromatin-level clock repression, and metabolic coupling through AMPK, SIRT1, and GSK-3β. What is needed now is the human evidence: phase-aware, exposure-informed, adequately powered trials that can determine whether manipulating melatonin signaling at the right biological time, at the right dose, and for the right indication can improve outcomes for surgical patients. Until those trials are done, the most defensible clinical use of melatonin in the perioperative period remains its best-established one, preoperative anxiolysis in adults, while the larger promise of chronotherapeutic anesthesia waits on better-designed evidence.

Subject of Research: Circadian and melatonin signaling mechanisms in general anesthesia and their perioperative therapeutic implications

Article Title: Circadian–melatonin signaling in general anesthesia: molecular mechanisms and perioperative implications

Article References: Mui, W.-C., Hou, Y.-C., Liao, Y.-C., & Lu, K.-C. (2026). Circadian–melatonin signaling in general anesthesia: molecular mechanisms and perioperative implications. Frontiers in Pharmacology, 17, Article 1960152. https://doi.org/10.3389/fphar.2026.1960152

Image Credits: AI Generated

DOI: 10.3389/fphar.2026.1960152

Keywords: circadian rhythm, melatonin, general anesthesia, suprachiasmatic nucleus, CLOCK-BMAL1, perioperative medicine, postoperative delirium, preoperative anxiolysis, MT1 receptor, MT2 receptor, chronotherapy, molecular clock

The researchers approached the problem by building a compartmentalized mathematical model of the suprachiasmatic nucleus, one that explicitly incorporates the heat shock protein pathway alongside the core circadian oscillator. Heat shock proteins are molecular chaperones that cells deploy when temperatures rise, and they interact with clock gene networks in ways that can alter the timing of molecular feedback loops. By embedding this thermal response machinery into a network model of the suprachiasmatic nucleus, the team could simulate how the entire structure reacts when heat stimuli arrive. The goal was not merely to reproduce known behavior but to identify which features of the network’s organization are responsible for its remarkable temperature resistance.

The model’s first test was to recapitulate a striking experimental observation: heat stimuli can entrain peripheral clocks to an inverted phase, meaning the peripheral oscillator locks onto the thermal cycle in a phase relationship opposite to what might be expected, while the suprachiasmatic nucleus maintains its normal phase and resists entrainment altogether. When the researchers ran their simulations, the compartmentalized model successfully reproduced both behaviors. Peripheral-like oscillators shifted as experiments show they should, and the modeled suprachiasmatic nucleus held its ground. This dual success was critical, because it suggested the model had captured the essential ingredients that distinguish central from peripheral temperature responses, rather than merely fitting one behavior at the expense of the other.

With a model that behaved like the biological system, the team could then interrogate it in ways no experiment easily allows. The key insight that emerged concerns phase heterogeneity within the suprachiasmatic nucleus itself. The structure is not a homogeneous blob of synchronized neurons. Its subregions, most notably the dorsal and ventral compartments, run their circadian oscillators at slightly different phases, a well-documented feature of the real nucleus. The simulations revealed that this intrinsic phase difference is not incidental. It is the engine of temperature resistance. When a heat stimulus hits the entire nucleus at once, the dorsal and ventral regions respond to the thermal input from their different starting phases, and their individual phase shifts pull in divergent directions.

The consequence of this divergence is an attenuated net shift of the overall suprachiasmatic nucleus phase. In other words, the two subregions partially cancel each other out. Where a peripheral tissue, acting as a single relatively uniform oscillator, would shift its phase substantially in response to a thermal cycle, the suprachiasmatic nucleus absorbs the same input and produces only a small net change because its internal components are pulling against one another. Temperature resistance, in this view, is not a property of individual suprachiasmatic neurons, whose molecular clocks resemble those of peripheral cells, but an emergent property of the network’s spatial organization.

The researchers also examined the mode of thermal input and found a second layer of robustness. In the natural situation, thermal stimulation reaches the dorsal and ventral regions concurrently, and the model indicates that this simultaneous stimulation may actively enhance the nucleus’s resistance to temperature entrainment. Because both compartments are pushed at the same moment from their offset phases, the opposing phase responses are maximally aligned against each other, reinforcing the cancellation effect. Had the thermal input arrived in a pattern that preferentially engaged one subregion at a time, the protective cancellation would presumably be weaker. This suggests that the way the body delivers thermal information to the nucleus, not just the way the nucleus is built, contributes to its stability.

One of the most intriguing implications of the work concerns how temperature entrainment resistance compares with the better-studied phenomenon of photic entrainment. Light resets the suprachiasmatic nucleus through the retinohypothalamic tract, a dedicated neural pathway that delivers photic information in a spatially and temporally structured way, and the nucleus integrates that input to track the day-night cycle. The new results suggest that the mechanisms guarding against temperature entrainment are mechanistically distinct from those governing light entrainment. The nucleus does not resist heat because it lacks the molecular machinery to respond; individual cells almost certainly possess it. It resists because of how the network is wired and phased. This distinction matters for anyone modeling circadian biology, because it means the rules that apply to light cannot simply be transplanted to temperature.

The study also reframes the long-standing question of why peripheral tissues are so temperature sensitive. From an evolutionary standpoint, a liver or kidney that can align its metabolic rhythms with daily thermal fluctuations may gain a functional advantage, fine-tuning enzyme activity and metabolic flux to the body’s thermal environment. The master clock, by contrast, must remain stable precisely because it coordinates all the peripheral oscillators. If the conductor of the orchestra were swayed by every passing temperature change, the entire circadian system would lose coherence. The compartmentalized architecture of the suprachiasmatic nucleus, with its phase-offset subregions, appears to be a design solution to this stability problem, allowing the central pacemaker to filter out thermal noise while remaining exquisitely sensitive to light.

Technically, the achievement rests on the integration of the heat shock protein pathway into a compartmentalized circadian model, a coupling that had not been systematically explored at the network level for the suprachiasmatic nucleus. Heat shock proteins respond to temperature elevation by altering the availability and activity of proteins within the clock’s transcriptional-translational feedback loops, effectively changing the parameters of the oscillator in a temperature-dependent manner. By representing the nucleus as distinct compartments with defined phase relationships and shared thermal input, the model could capture how a stimulus that would strongly shift a single oscillator produces only a weak net effect across the coupled network. The fidelity of the model to experimental observations, including the inverted phase entrainment seen in peripheral clocks, lends credibility to the mechanistic claims that follow from the simulations.

The broader significance of this work extends beyond circadian biology into the general principles of robust biological networks. It demonstrates that resistance to an external forcing signal can arise not from insensitivity at the component level but from structured heterogeneity across a network, a principle with echoes in neural circuits, gene regulatory systems, and engineered control systems alike. For circadian researchers, the model generates testable predictions: disrupting the phase relationships between dorsal and ventral subregions, or altering the spatial pattern of thermal input, should weaken the nucleus’s temperature resistance in measurable ways. For the wider public, the study offers a satisfying answer to a deceptively simple question. The reason a feverish day or a hot afternoon does not scramble your body’s master schedule is that the brain’s clock is not one clock but a carefully phased assembly of clocks, built so that its parts hold each other in place when the heat tries to push them around.

Subject of Research: Computational modeling of temperature entrainment resistance in the mammalian suprachiasmatic nucleus circadian clock

Article Title: A compartmentalized SCN model explains temperature resistance through interregional phase differences

Article References: Yu, F., Yang, L., & Yan, J. (2026). A compartmentalized SCN model explains temperature resistance through interregional phase differences. PLOS Computational Biology, 22(9), e1014831. https://doi.org/10.1371/journal.pcbi.1014831

Image Credits: AI Generated

DOI: 10.1371/journal.pcbi.1014831

Keywords: circadian rhythms, suprachiasmatic nucleus, temperature entrainment, heat shock proteins, computational biology, phase heterogeneity, dorsal SCN, ventral SCN, peripheral clocks, PLOS Computational Biology, circadian stability, systems biology

The team deployed an unusually broad technical arsenal to interrogate the question. They combined electrical stimulation of the SCN region in brain slices with visual stimulation of light-exposed animals, perforated multielectrode array recordings that capture the firing of many neurons simultaneously over hours, c-Fos mapping to visualise which cells were activated in the living brain, and detailed neuroanatomical tracing of retinal projections. This multi-pronged strategy matters because no single method could disentangle the two influences at play: the time-of-day signal emanating from the SCN and the moment-to-moment photic signal arriving from the eye.

The first surprise was the sheer diversity of responses. Across the midline hypothalamus—encompassing regions such as the paraventricular nucleus, the dorsomedial and anterior dorsomedial hypothalamus, the anterior hypothalamic area, the anterior ventromedial hypothalamus, the arcuate nucleus, the medial preoptic area, the lateral hypothalamic area and the retrochiasmatic area—the researchers found distinct cell populations that fell into different functional classes. Some received inhibitory input of SCN origin, some excitatory input, and some both. When the SCN region was stimulated electrically in slices, hypothalamic neurons responded with a mixture of fast excitatory postsynaptic currents and inhibitory currents, revealing that the master clock does not simply broadcast a uniform suppressive message to its hypothalamic targets.

Crucially, the responses were not confined to SCN-derived signals. The recordings revealed excitatory and inhibitory responses of retinal origin in hypothalamic cells, indicating that photic information arrives through routes that bypass, or at least run in parallel to, the classical SCN relay. The pharmacology supported this: blocking ionotropic glutamate receptors abolished the fast excitatory components, while the GABA receptor antagonist bicuculline unmasked inhibitory drive, consistent with glutamate and GABA acting as the principal transmitters carrying both circadian and retinal messages into these downstream nuclei.

Ex vivo recordings of hypothalamic slices maintained in artificial cerebrospinal fluid added a temporal dimension. Even when isolated from the body, different hypothalamic cell populations displayed divergent circadian activity patterns—some firing vigorously at what would be daytime in the donor animal, others peaking at night, and others showing phase relationships that shifted depending on where in the hypothalamus the cells resided. This differential phase resetting means the hypothalamus is not a passive uniform follower of the SCN clock; it hosts multiple local oscillators with distinct timing signatures, each potentially tuned to different physiological outputs such as hormone secretion, thermoregulation, feeding or sleep-wake control.

Back in the living animal, the picture sharpened further. Light-evoked activity in the hypothalamus in vivo was dominated by melanopsin—the photopigment found in intrinsically photosensitive retinal ganglion cells, the specialised neurons that also drive circadian photoentrainment and the pupil reflex. The melanopsin-dominated character of the hypothalamic visual responses aligned neatly with the distribution of direct retinal projections traced by the anatomical experiments: the regions that received the densest retinal innervation were the ones showing the strongest light-driven activation. Neutral density filters that attenuated light intensity, and comparisons across Zeitgeber times, allowed the team to separate the photic component from the circadian component of hypothalamic firing.

The c-Fos mapping experiments then delivered the study’s most visually compelling result. When the researchers quantified c-Fos expression—the classic molecular fingerprint of recent neuronal activation—across hypothalamic subregions, they found a striking mosaic. Some discrete subregions were dominated by circadian signals, lighting up according to time of day regardless of illumination. Others were dominated by light, responding to illumination irrespective of clock phase. And a third set responded to both, integrating the internal clock with the external light environment. This anatomical segregation of circadian, photic and combined influences means the hypothalamus is organised into parallel channels rather than a single SCN-gated pipeline.

The implications ripple outward well beyond rodent neuroanatomy. The hypothalamic nuclei implicated in this study are major effector sites for physiology: the paraventricular nucleus orchestrates the hormonal stress axis and autonomic output, the dorsomedial hypothalamus helps coordinate sleep-wake and feeding rhythms, the arcuate nucleus governs appetite and energy balance, and the ventromedial hypothalamus is central to defensive behaviour and metabolic regulation. If light can modulate these circuits directly, through melanopsin-driven retinal input, then environmental illumination has a far more immediate and granular influence on physiology than the SCN-suppression model allowed. It also offers new substrates for understanding how light can be adaptive—sharpening daily rhythms—and how it can be disruptive, as in the metabolic and mood disturbances associated with irregular light exposure, shift work and excessive evening screen use.

The study also reframes how we think about the SCN itself. Rather than a despotic conductor whose output wholly determines hypothalamic state, the master clock emerges as one player in a distributed network, contributing inhibitory and excitatory signals that interact with independent retinal channels. The finding that SCN-derived responses include both inhibitory and excitatory components challenges the textbook framing of daytime SCN output as uniformly suppressive on downstream hypothalamic effectors. Instead, the SCN appears to shape hypothalamic activity with the same kind of push-pull synaptic logic found elsewhere in the brain, while the retina delivers a second, parallel stream of information that can act on the same nuclei on its own timescale.

Methodologically, the work sets a benchmark for how to disentangle circadian and photic influences on neural activity. By pairing long-duration ex vivo multielectrode recordings—capable of tracking slice activity across the circadian cycle—with in vivo visual stimulation, pharmacological dissection of glutamatergic and GABAergic transmission, and quantitative c-Fos mapping validated against anatomical templates, the Manchester team built a converging chain of evidence in which each line of attack compensates for the limitations of the others. The result is a coherent map of where, when and how light and time-of-day signals converge in the hypothalamus. What remains to be explored is how these parallel channels influence specific physiological outputs—whether direct retinal drive to the paraventricular nucleus, for instance, acutely modulates stress hormones, or whether melanopsin input to feeding circuits contributes to the appetite-suppressing effects of bright light. The authors’ data establish that light-dependent activity across the anterior midline hypothalamus is surprisingly extensive, and in doing so they open a rich new seam for research into how the light environment shapes, and sometimes scrambles, the daily biology of mammals—including, very likely, ourselves.

Subject of Research: Parallel retinal and circadian signalling pathways regulating light-dependent activity in the mouse hypothalamus

Article Title: Parallel retinal and circadian signalling channels organise mouse hypothalamic activity

Article References: Gurung, B., Harding, C., Mouland, J. W., Sahid, N., Ray, H., Bechtold, D. A., & Brown, T. M. (2026). Parallel retinal and circadian signalling channels organise mouse hypothalamic activity. BMC Biology. https://doi.org/10.1186/s12915-026-02746-w

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02746-w

Keywords: suprachiasmatic nucleus, hypothalamus, circadian rhythms, melanopsin, intrinsically photosensitive retinal ganglion cells, retinohypothalamic tract, c-Fos mapping, multielectrode recordings, paraventricular nucleus, dorsomedial hypothalamus, light exposure, electrophysiology